The disulfide-linked homodimeric proteins vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) are both members of the VEGF family of growth factors. VEGF and PlGF proteins share primary structural as well as limited amino acid sequence homology with the A and B chains of PDGF. All eight cysteine residues involved in intra- and inter-chain disulfides are conserved among these growth factors. In their PDGF-like regions, VEGF and PlGF also share approximately 53% amino acid sequence similarity. E. coli-expressed monomers of PlGF and VEGF can be refolded in vitro to form PlGF/VEGF heterodimers. The purified recombinant VEGF/PlGF heterodimers and VEGF homodimers have potent mitogenic effects on endothelial cells. However, VEGF/PlGF heterodimers display approximately 50-fold less mitogenic activity than VEGF homodimers. In contrast, PlGF homodimers have little or no mitogenic effect on endothelial cells. The presence of natural VEGF/PlGF heterodimers in the conditioned media of a number of human tumor cell lines has been demonstrated using a VEGF/PlGF heterodimer specific ELISA.
Recombinant Human VEGF/PlGF Heterodimer Protein
R&D Systems | Catalog # 297-VP
Discontinued Product
297-VP has been discontinued.
View all VEGF/PlGF Heterodimer products.
Key Product Details
Source
E. coli
Accession Number
Structure / Form
Disulfide-linked heterodimer
Applications
Bioactivity
Loading...
Product Specifications
Source
E. coli-derived human VEGF/PlGF Heterodimer protein
| Human VEGF (Ala27-Arg191) Accession # AAM03108 |
| Human PlGF (Ala21-Arg149) Accession # AAD30179 |
| N-terminus | C-terminus |
Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Ala27 (VEGF) & Ala21 (PlGF)
Predicted Molecular Mass
19 kDa (VEGF) & 14.5 kDa (PIGF)
Activity
Measured in a cell proliferation assay using HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323.
The ED50 for this effect is 15‑75 ng/mL.
The ED50 for this effect is 15‑75 ng/mL.
Formulation, Preparation, and Storage
297-VP
| Formulation | Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
| Reconstitution | Reconstitute at 50 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Calculators
Background: VEGF/PlGF Heterodimer
Long Name
Vascular Endothelial Growth Factor/Placenta Growth Factor Heterodimer
Additional VEGF/PlGF Heterodimer Products
Product Documents for Recombinant Human VEGF/PlGF Heterodimer Protein
Product Specific Notices for Recombinant Human VEGF/PlGF Heterodimer Protein
For research use only
Related Research Areas
Citations for Recombinant Human VEGF/PlGF Heterodimer Protein
Customer Reviews for Recombinant Human VEGF/PlGF Heterodimer Protein
There are currently no reviews for this product. Be the first to review Recombinant Human VEGF/PlGF Heterodimer Protein and earn rewards!
Have you used Recombinant Human VEGF/PlGF Heterodimer Protein?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review